These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8000245)

  • 41. [Bartter's syndrome in adults. Case report with light- and electron-microscopic findings].
    Schmidt P; Kopsa H; Kronenberg KH; Meyer D; Zazgornik J; Kotzaurek R; Neumann E
    Dtsch Med Wochenschr; 1973 Apr; 98(14):723-6 passim. PubMed ID: 4695399
    [No Abstract]   [Full Text] [Related]  

  • 42. Juxtaglomerular cell hyperplasia and secondary hyperaldosteronism (Bartter's syndrome): a re-evaluation of the pathophysiology.
    Cannon PJ; Leeming JM; Sommers SC; Winters RW; Laragh JH
    Medicine (Baltimore); 1968 Mar; 47(2):107-31. PubMed ID: 4869871
    [No Abstract]   [Full Text] [Related]  

  • 43. Increased transforming growth factor-beta2 expression in the glomerular arteriole of the juxtaglomerular apparatus in a Bartter's-like syndrome.
    Yamamoto T; Takahashi T; Yonemura K; Matsui K; Nagase M; Hishida A
    Hum Pathol; 1999 Aug; 30(8):992-5. PubMed ID: 10452516
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A study of the inhibition of the renin-angiotensin system in renal potassium wasting syndromes, including Bartter's syndrome.
    Godard C; Vallotton MB; Broyer M; Royer P
    Helv Paediatr Acta; 1972 Nov; 27(5):495-511. PubMed ID: 4344982
    [No Abstract]   [Full Text] [Related]  

  • 45. The morphology of juxtaglomerular cell hyperplasia and hypertrophy in normotensive rats and monkeys given an angiotensin II receptor antagonist.
    Owen RA; Molon-Noblot S; Hubert MF; Kindt MV; Keenan KP; Eydelloth RS
    Toxicol Pathol; 1995; 23(3):606-19. PubMed ID: 7659963
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of long-term treatment with spironolactone on sodium pump abnormalities in the red blood cells of patients with Bartter's syndrome.
    Horký K; Schreiber V; Dvoráková J
    Exp Clin Endocrinol; 1984 Jul; 84(1):105-11. PubMed ID: 6090182
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A case of Bartter's syndrome with chronic renal failure due to chronic interstitial nephritis].
    Maekawa K; Fujimoto T; Shiiki H; Kanauchi M; Fujii Y; Dohi K; Murata K; Takayanagi T
    Nihon Jinzo Gakkai Shi; 1998 May; 40(4):309-14. PubMed ID: 9654916
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Some observations on the pathogenesis of Bartter's syndrome.
    Modlinger RS; Nicolis GL; Krakoff LR; Gabrilove JL
    N Engl J Med; 1973 Nov; 289(19):1022-4. PubMed ID: 4355057
    [No Abstract]   [Full Text] [Related]  

  • 49. The morphology of juxtaglomerular cell hyperplasia and hypertrophy in normotensive rats and monkeys given an angiotensin II receptor antagonist.
    Owen RA; Molon-Noblot S; Hubert MF; Kindt MV; Keenan KP; Eydelloth RS
    Toxicol Pathol; 1994; 22(6):606-19. PubMed ID: 7732278
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bartter's syndrome in early infancy. Physiologic, light and electron microscopic observations.
    Wald MK; Perrin EV; Bolande RP
    Pediatrics; 1971 Jan; 47(1):Suppl 2:254+. PubMed ID: 5551039
    [No Abstract]   [Full Text] [Related]  

  • 51. [The paradoxic behavior of the kidney in Bartter's syndrome and other processes].
    Méndez Aparicio FM
    Rev Clin Esp; 1980 Oct; 159(2):107-14. PubMed ID: 7209032
    [No Abstract]   [Full Text] [Related]  

  • 52. Self-induced secondary hyperaldosteronism simulating Bartter's syndrome.
    Ben-Ishay D; Levy M; Birnbaum D
    Isr J Med Sci; 1972 Nov; 8(11):1835-9. PubMed ID: 4647211
    [No Abstract]   [Full Text] [Related]  

  • 53. [Morphologic studies of the juxtaglomerular apparatus of the rat treated with furosemide].
    Martines F; Demetrio G; Di Pentima G; Batolo D
    Arch De Vecchi Anat Patol; 1977 Dec; 62(2-3):415-24. PubMed ID: 756227
    [No Abstract]   [Full Text] [Related]  

  • 54. Case studies of siblings with juxtaglomerular hyperplasia and secondary aldosteronism associated with severe azotemia and renal rickets--Bartter's syndrome or disease?
    Arant BS; Brackett NC; Young RB; Still WJ
    Pediatrics; 1970 Sep; 46(3):344-61. PubMed ID: 4323412
    [No Abstract]   [Full Text] [Related]  

  • 55. A sibship with Bartter's syndrome: failure of total adrenalectomy to correct the potassium wasting.
    Trygstad CW; Mangos JA; Bloodworth JM; Lobeck CC
    Pediatrics; 1969 Aug; 44(2):234-42. PubMed ID: 4308821
    [No Abstract]   [Full Text] [Related]  

  • 56. FK 506-induced juxtaglomerular apparatus hyperplasia and tubular damage in rat kidney--morphologic and biologic analysis.
    Yamada K; Sugisaki Y; Akimoto M; Yamanaka N
    Transplant Proc; 1992 Aug; 24(4):1396-8. PubMed ID: 1379756
    [No Abstract]   [Full Text] [Related]  

  • 57. [Changes in the juxtaglomerular apparatus of rat kidneys under experimental hormonal influence].
    Rodriguez S
    Verh Anat Ges; 1969; 63():99-105. PubMed ID: 5378588
    [No Abstract]   [Full Text] [Related]  

  • 58. [Bartter's syndrome and pseudo-Bartter syndrome].
    Kono T; Yoshimi T; Endo J; Nakai Y
    Nihon Rinsho; 1971 Mar; 29(3):960-6. PubMed ID: 4928556
    [No Abstract]   [Full Text] [Related]  

  • 59. Factitious Bartter's syndrome.
    Rosenblum M; Simpson DP; Evenson M
    Arch Intern Med; 1977 Sep; 137(9):1244-5. PubMed ID: 901095
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical analysis of 6 cases of Bartter syndrome].
    Yin FM; Zheng FQ; Zhang X; Wu MJ; Wei HY; Ma ZS; Lu B; Qiu MC
    Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(8):528-31. PubMed ID: 21418853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.